4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000171
Chairperson & CEO sold 9,500 shares at an average $582.76 ($5,536,235)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-23 | Sale : show line 2 in the form 10b5-1 | −200 | $577.68 | $115,535 | 333,743 | I |
| 2026-10-23 | Sale : show line 3 in the form 10b5-1 | −700 | $578.80 | $405,160 | 333,043 | I |
| 2026-10-23 | Sale : show line 4 in the form 10b5-1 | −1,038 | $579.74 | $601,773 | 332,005 | I |
| 2026-10-23 | Sale : show line 5 in the form 10b5-1 | −1,017 | $580.78 | $590,653 | 330,988 | I |
| 2026-10-23 | Sale : show line 6 in the form 10b5-1 | −1,650 | $581.82 | $960,006 | 329,338 | I |
| 2026-10-23 | Sale : show line 7 in the form 10b5-1 | −1,732 | $582.78 | $1,009,367 | 327,606 | I |
| 2026-10-23 | Sale : show line 8 in the form 10b5-1 | −427 | $583.83 | $249,297 | 327,179 | I |
| Open-market sales · 9,500 sh · avg $582.76 · $5,536,235 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-23 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −9,500 | 166,910 | I |
Loading xslF345X06/primarydocument.xml…